The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Oral Rotavirus Vaccine-Global Market Insights and Sales Trends 2025
Synopsis
An oral vaccine against rotavirus infection is given to babies as part of their routine childhood vaccinations.
The global Oral Rotavirus Vaccine market size is expected to reach US$ 14890 million by 2029, growing at a CAGR of 12.8% from 2023 to 2029. The market is mainly driven by the significant applications of Oral Rotavirus Vaccine in various end use industries. The expanding demands from the Hospital, Vaccination Station and Other, are propelling Oral Rotavirus Vaccine market. Rotarix, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the RotaTeq segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Oral Rotavirus Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Oral Rotavirus Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Oral Rotavirus Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Oral Rotavirus Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Oral Rotavirus Vaccine covered in this report include GSK, Sanofi-Pasteur, Merck, Biological E. Limited, China National Biotec Group and Sinovac Biotech, etc.
The global Oral Rotavirus Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK
Sanofi-Pasteur
Merck
Biological E. Limited
China National Biotec Group
Sinovac Biotech
Global Oral Rotavirus Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Oral Rotavirus Vaccine market, Segment by Type:
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou lamb
Global Oral Rotavirus Vaccine market, by Application
Hospital
Vaccination Station
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Oral Rotavirus Vaccine companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
An oral vaccine against rotavirus infection is given to babies as part of their routine childhood vaccinations.
The global Oral Rotavirus Vaccine market size is expected to reach US$ 14890 million by 2029, growing at a CAGR of 12.8% from 2023 to 2029. The market is mainly driven by the significant applications of Oral Rotavirus Vaccine in various end use industries. The expanding demands from the Hospital, Vaccination Station and Other, are propelling Oral Rotavirus Vaccine market. Rotarix, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the RotaTeq segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Oral Rotavirus Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Oral Rotavirus Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Oral Rotavirus Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Oral Rotavirus Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Oral Rotavirus Vaccine covered in this report include GSK, Sanofi-Pasteur, Merck, Biological E. Limited, China National Biotec Group and Sinovac Biotech, etc.
The global Oral Rotavirus Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK
Sanofi-Pasteur
Merck
Biological E. Limited
China National Biotec Group
Sinovac Biotech
Global Oral Rotavirus Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Oral Rotavirus Vaccine market, Segment by Type:
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou lamb
Global Oral Rotavirus Vaccine market, by Application
Hospital
Vaccination Station
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Oral Rotavirus Vaccine companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Oral Rotavirus Vaccine
1.1 Oral Rotavirus Vaccine Market Overview
1.1.1 Oral Rotavirus Vaccine Product Scope
1.1.2 Oral Rotavirus Vaccine Market Status and Outlook
1.2 Global Oral Rotavirus Vaccine Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Oral Rotavirus Vaccine Market Size by Region (2018-2029)
1.4 Global Oral Rotavirus Vaccine Historic Market Size by Region (2018-2023)
1.5 Global Oral Rotavirus Vaccine Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Oral Rotavirus Vaccine Market Size (2018-2029)
1.6.1 North America Oral Rotavirus Vaccine Market Size (2018-2029)
1.6.2 Europe Oral Rotavirus Vaccine Market Size (2018-2029)
1.6.3 Asia-Pacific Oral Rotavirus Vaccine Market Size (2018-2029)
1.6.4 Latin America Oral Rotavirus Vaccine Market Size (2018-2029)
1.6.5 Middle East & Africa Oral Rotavirus Vaccine Market Size (2018-2029)
2 Oral Rotavirus Vaccine Market by Type
2.1 Introduction
2.1.1 Rotarix
2.1.2 RotaTeq
2.1.3 Rotavac
2.1.4 Rotavin-M1
2.1.5 Lanzhou lamb
2.2 Global Oral Rotavirus Vaccine Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Oral Rotavirus Vaccine Historic Market Size by Type (2018-2023)
2.2.2 Global Oral Rotavirus Vaccine Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Oral Rotavirus Vaccine Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Oral Rotavirus Vaccine Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Oral Rotavirus Vaccine Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Oral Rotavirus Vaccine Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Oral Rotavirus Vaccine Revenue Breakdown by Type (2018-2029)
3 Oral Rotavirus Vaccine Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Vaccination Station
3.1.3 Other
3.2 Global Oral Rotavirus Vaccine Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Oral Rotavirus Vaccine Historic Market Size by Application (2018-2023)
3.2.2 Global Oral Rotavirus Vaccine Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Oral Rotavirus Vaccine Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Oral Rotavirus Vaccine Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Oral Rotavirus Vaccine Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Oral Rotavirus Vaccine Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Oral Rotavirus Vaccine Revenue Breakdown by Application (2018-2029)
4 Oral Rotavirus Vaccine Competition Analysis by Players
4.1 Global Oral Rotavirus Vaccine Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Rotavirus Vaccine as of 2022)
4.3 Date of Key Players Enter into Oral Rotavirus Vaccine Market
4.4 Global Top Players Oral Rotavirus Vaccine Headquarters and Area Served
4.5 Key Players Oral Rotavirus Vaccine Product Solution and Service
4.6 Competitive Status
4.6.1 Oral Rotavirus Vaccine Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 GSK
5.1.1 GSK Profile
5.1.2 GSK Main Business
5.1.3 GSK Oral Rotavirus Vaccine Products, Services and Solutions
5.1.4 GSK Oral Rotavirus Vaccine Revenue (US$ Million) & (2018-2023)
5.1.5 GSK Recent Developments
5.2 Sanofi-Pasteur
5.2.1 Sanofi-Pasteur Profile
5.2.2 Sanofi-Pasteur Main Business
5.2.3 Sanofi-Pasteur Oral Rotavirus Vaccine Products, Services and Solutions
5.2.4 Sanofi-Pasteur Oral Rotavirus Vaccine Revenue (US$ Million) & (2018-2023)
5.2.5 Sanofi-Pasteur Recent Developments
5.3 Merck
5.3.1 Merck Profile
5.3.2 Merck Main Business
5.3.3 Merck Oral Rotavirus Vaccine Products, Services and Solutions
5.3.4 Merck Oral Rotavirus Vaccine Revenue (US$ Million) & (2018-2023)
5.3.5 Biological E. Limited Recent Developments
5.4 Biological E. Limited
5.4.1 Biological E. Limited Profile
5.4.2 Biological E. Limited Main Business
5.4.3 Biological E. Limited Oral Rotavirus Vaccine Products, Services and Solutions
5.4.4 Biological E. Limited Oral Rotavirus Vaccine Revenue (US$ Million) & (2018-2023)
5.4.5 Biological E. Limited Recent Developments
5.5 China National Biotec Group
5.5.1 China National Biotec Group Profile
5.5.2 China National Biotec Group Main Business
5.5.3 China National Biotec Group Oral Rotavirus Vaccine Products, Services and Solutions
5.5.4 China National Biotec Group Oral Rotavirus Vaccine Revenue (US$ Million) & (2018-2023)
5.5.5 China National Biotec Group Recent Developments
5.6 Sinovac Biotech
5.6.1 Sinovac Biotech Profile
5.6.2 Sinovac Biotech Main Business
5.6.3 Sinovac Biotech Oral Rotavirus Vaccine Products, Services and Solutions
5.6.4 Sinovac Biotech Oral Rotavirus Vaccine Revenue (US$ Million) & (2018-2023)
5.6.5 Sinovac Biotech Recent Developments
6 North America
6.1 North America Oral Rotavirus Vaccine Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Oral Rotavirus Vaccine Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Oral Rotavirus Vaccine Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Oral Rotavirus Vaccine Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Oral Rotavirus Vaccine Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Oral Rotavirus Vaccine Market Dynamics
11.1 Oral Rotavirus Vaccine Industry Trends
11.2 Oral Rotavirus Vaccine Market Drivers
11.3 Oral Rotavirus Vaccine Market Challenges
11.4 Oral Rotavirus Vaccine Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
